The anti-tumor immune microenvironment in the Sonic Hedgehog subclass of medulloblastoma |
Emory University / Anna Kenney, PhD |
Innovation Grants |
2019 |
Georgia |
A novel mouse model of rhabdomyosarcoma |
Vanderbilt University Medical Center / Chin Chiang, PhD |
Innovation Grants |
2012 |
Tennessee |
Circulating Exosomes as Biomarkers of Medulloblastoma Progression, Metastasis, and Recurrence |
Weill Cornell Medical College / David Lyden, MD/PhD & Parveen Raju, MD/PhD |
Innovation Grants |
2016 |
New York |
Identifying New Therapeutic Targets in Fibrolamellar Hepatocellular Carcinoma |
Stanford University / Julien Sage, PhD |
Innovation Grants |
2018 |
California |
A leukemia organoid platform for dissection and targeting of tumor-niche interactions |
Columbia Institute for Cancer Genetics / Adolfo Ferrando, MD/PhD |
Innovation Grants |
2021 |
New York |
Molecular diagnostic, prognostic, and therapeutic approaches toward Ewing sarcoma.
|
Huntsman Cancer Institute / Stephen Lessnick |
Innovation Grants |
2009 |
Utah |
Advancing Program Development and Support for the Pediatric Experimental Therapeutics Program at The Children's Hospital, Denver
|
Children’s Hospital Colorado / Lia Gore, MD |
Phase I/II Infrastructure Grants |
2007 |
Colorado |
Increasing the Availability and Quality of Early Phase Clinical Trials Through the Addition of a Specialized Pediatric Advanced Nurse Practitioner
|
Children’s Memorial Hospital / Stewart Goldman |
Phase I/II Infrastructure Grants |
2008 |
Illinois |
Developmental Therapeutics and Translational Research Program
|
Children’s Hospital of Philadelphia / John Maris |
Phase I/II Infrastructure Grants |
2005 |
Pennsylvania |
Children's Hospital of Pittsburgh of UPMC Phase 1-2 Infrastructure Support Grant
|
University of Pittsburgh / Jean Tersak, MD |
Phase I/II Infrastructure Grants |
2013 |
Pennsylvania |